Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants

Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants

Optimal management of the patent ductus arteriosus (PDA) in preterm infants remains controversial. Therefore, studies identifying infants who are most likely to benefit from PDA treatment are needed.

Bibliographische Detailangaben
Veröffentlicht in:Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics. - 2014. - Amsterdam [u.a.]
1. Verfasser: Boghossian, Nansi S. (VerfasserIn)
Weitere Verfasser: Do, Barbara T. (BerichterstatterIn), Bell, Edward F. (BerichterstatterIn), Dagle, John M. (BerichterstatterIn), Brumbaugh, Jane E. (BerichterstatterIn), Stoll, Barbara J. (BerichterstatterIn), Vohr, Betty R. (BerichterstatterIn), Das, Abhik (BerichterstatterIn), Shankaran, Seetha (BerichterstatterIn), Sanchez, Pablo J. (BerichterstatterIn), Wyckoff, Myra H. (BerichterstatterIn), Bethany Ball, M. (BerichterstatterIn)
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2017
Zugriff auf das übergeordnete Werk:Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
Umfang:8
LEADER 01000caa a22002652 4500
001 ELV04071442X
003 DE-627
005 20230624075500.0
007 cr uuu---uuuuu
008 180725s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.earlhumdev.2017.07.011  |2 doi 
028 5 2 |a GBV00000000000137A.pica 
035 |a (DE-627)ELV04071442X 
035 |a (ELSEVIER)S0378-3782(17)30185-8 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
082 0 |a 610 
082 0 4 |a 610  |q DE-600 
082 0 4 |a 618.3/005  |q OCLC 
082 0 4 |a 610  |q VZ 
082 0 4 |a 610  |q VZ 
084 |a 44.45  |2 bkl 
100 1 |a Boghossian, Nansi S.  |e verfasserin  |4 aut 
245 1 0 |a Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants 
264 1 |c 2017 
300 |a 8 
336 |a nicht spezifiziert  |b zzz  |2 rdacontent 
337 |a nicht spezifiziert  |b z  |2 rdamedia 
338 |a nicht spezifiziert  |b zu  |2 rdacarrier 
520 |a Optimal management of the patent ductus arteriosus (PDA) in preterm infants remains controversial. Therefore, studies identifying infants who are most likely to benefit from PDA treatment are needed. 
700 1 |a Do, Barbara T.  |4 oth 
700 1 |a Bell, Edward F.  |4 oth 
700 1 |a Dagle, John M.  |4 oth 
700 1 |a Brumbaugh, Jane E.  |4 oth 
700 1 |a Stoll, Barbara J.  |4 oth 
700 1 |a Vohr, Betty R.  |4 oth 
700 1 |a Das, Abhik  |4 oth 
700 1 |a Shankaran, Seetha  |4 oth 
700 1 |a Sanchez, Pablo J.  |4 oth 
700 1 |a Wyckoff, Myra H.  |4 oth 
700 1 |a Bethany Ball, M.  |4 oth 
773 0 8 |i Enthalten in  |n Elsevier Science  |a Abdel-Aziz, Tarek Ezzat ELSEVIER  |t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics  |d 2014  |g Amsterdam [u.a.]  |w (DE-627)ELV022803173 
773 1 8 |g volume:113  |g year:2017  |g pages:10-17  |g extent:8 
856 4 0 |u https://doi.org/10.1016/j.earlhumdev.2017.07.011  |3 Volltext 
912 |a GBV_USEFLAG_U 
912 |a GBV_ELV 
912 |a SYSFLAG_U 
912 |a SSG-OLC-PHA 
912 |a GBV_ILN_130 
912 |a GBV_ILN_350 
936 b k |a 44.45  |j Immunologie  |q VZ 
951 |a AR 
952 |d 113  |j 2017  |h 10-17  |g 8 
953 |2 045F  |a 610